MEI Pharma’s $100M Move to Litecoin: Exploring Potential Impacts on Market Dynamics and Institutional Adoption
Main Idea
MEI Pharma has invested $100 million in Litecoin, marking the first time a U.S.-listed company has adopted Litecoin as a treasury asset, leading to a price increase from $107.58 to $124 per LTC.
Key Points
1. MEI Pharma invested $100 million in Litecoin as its primary treasury acquisition on August 4, 2025.
2. This is the first instance of a U.S.-listed company using Litecoin as a reserve asset.
3. The investment led to a price appreciation of Litecoin from $107.58 to $124 per LTC.
4. The move signals growing institutional interest in Litecoin, beyond Bitcoin and Ethereum.
5. The investment enhances market liquidity and stability for Litecoin.
Description
Are You Chasing New Coins? Catch the newest crypto opportunities. Be the first to buy, be the first to win! Click here to discover new altcoins! MEI Pharma has
Latest News
- FUZZY PANDA SHORT RCAT2025-08-15 14:32:02
- OPENDOOR ANNOUNCES CEO SEARCH2025-08-15 13:03:49
- $USELESS listed on Binance futures2025-08-15 10:49:47
- BERKSHIRE HATHAWAY ADDS UNH, NUE, LEN, DHI, LAMR IN 2Q: 13F2025-08-14 20:18:07
- Lido Co-founder: Plans to use stETH to repurchase LDO mechanism, final repurchase plan to be determined by the end of the year2025-08-14 15:12:41